AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymifine M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Propel Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glymifine M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to respond. Consistent meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their doctor before use. Consult your doctor before using Diabex Duo if pregnant or breastfeeding. Regular blood sugar checks are necessary, along with potential blood tests to monitor blood cell counts and liver function.

Uses of Glymifine M 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glymifine M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glymifine M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Take this tablet with food.

Common Side effects of Glymifine M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glymifine M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take the Glymifine M 1mg/500mg tablet with food.

How Glymifine M 1mg/500mg Tablet works:

Glymifine M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glymifine M 1mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glymifine M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Glymifine M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glymifine M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. Glymifine M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glymifine M 1mg/500mg tablets cautiously. Dosage modification may be necessary for these patients. A physician's consultation is advised. In those with mild to moderate liver disease, Glymifine M 1mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe liver disease.

What if you forget to take Glymifine M 1mg/500mg Tablet :

Should you forget a Glymifine M 1mg/500mg Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glymifine M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glymifine M 1mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glymifine M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glymifine M 1mg/500mg Tablets and seek immediate medical attention.
Glymifine M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. Glymifine M is not suitable for type 1 diabetes.
Glymifine M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glymifine M 1mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glymifine M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glymifine M 1mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glymifine M 1mg/500mg Tab...
38
MRP 46
17% off